Endocrine Society
@endocrinesociety.bsky.social
740 followers 300 following 360 posts
We unite, lead, and grow the global endocrine community to accelerate scientific breakthroughs and improve health worldwide. endocrine.org
Posts Media Videos Starter Packs
Pinned
endocrinesociety.bsky.social
We are seeking proposals for the launch of our Science Summits, designed to highlight basic science topics while encouraging discussion, collaboration, and innovation. Our meeting series will serve the education and collaboration needs of basic and clinical scientists: https://bit.ly/4pN7dne
endocrinesociety.bsky.social
Insulin Delivery Systems | Listen to Grazia Aleppo, MD, and Diana Isaacs, PharmD, discuss type 1 diabetes and related technology in our @endocrinenews.bsky.social Podcast: https://bit.ly/46SVxrq #endocrinology #diabetes #insulin #EndoSky
endocrinesociety.bsky.social
Endocrine Signals Blog | We are seeking proposals for our Science Summits. These small meetings, of no more than 200 attendees, are intended to serve the education and collaboration needs of basic and clinical scientists. Read more: https://bit.ly/4mTjWSM #endocrinology #EndoSky
endocrinesociety.bsky.social
Member @smahalingaiahmd.bsky.social describes how NIH funding cuts stalled her research into air pollution and women’s reproductive health via @nytimes.com (bit.ly/4h6rWyo). Join our campaign to urge Congress to protect NIH research funding (bit.ly/4n0cl4B) (1/2) #EndoSky
bit.ly
endocrinesociety.bsky.social
Acromegaly Patients Face Increased Cancer Risk | People who have the growth hormone disorder acromegaly are more likely to develop various types of cancer, according to research presented at ENDO 2025. Lead researcher Hitam Hagog Natour, MD, describes the study: https://bit.ly/4nGbEi4 #endocrinology
YouTube
Share your videos with friends, family, and the world
bit.ly
endocrinesociety.bsky.social
Tirzepatide reduces breast cancer growth in mouse study | A mouse model found the anti-obesity medication tirzepatide slowed the growth of obesity-associated breast cancer. Amanda Kucinskas, BS, explains the poster findings she presented at ENDO 2025: https://bit.ly/4mRLxUc #endocrinology #EndoSky
YouTube
Share your videos with friends, family, and the world
bit.ly
endocrinesociety.bsky.social
GLP-1s show promise in treating alcohol and drug addiction | A popular class of therapies for treating #diabetes and #obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in #JES. Read more in @Endocrine_News: https://bit.ly/4h7BKs6
endocrinesociety.bsky.social
GLP-1s show promise in treating alcohol and drug addiction | A popular class of therapies for treating #diabetes and #obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in #JES. Read more in @endocrinenews.bsky.social: bit.ly/4h7BKs6
https://bit.ly/4h7BK…
Reposted by Endocrine Society
lmfendo.bsky.social
Is it June yet? 🤗 #ENDO2026
@endocrinesociety.bsky.social
endocrinesociety.bsky.social
Over the weekend, our Annual Meeting Steering Committee (AMSC) gathered to lay out the groundwork for ENDO 2026 in Chicago, Illinois on June 13–16! We would like to extend our gratitude to everyone on the AMSC for their hard work: bit.ly/4n9vcuB #endocrinology #ENDO2026
endocrinesociety.bsky.social
Browse the latest Thematic Issue from @endosocjournals.bsky.social focusing on Neuroendocrinology. This issue highlights a selection of recently published articles that focused on interactions between the endocrine and nervous system. Read the articles today: bit.ly/3IPhLl1
endocrinesociety.bsky.social
The Long Academic Journey to Commercialization | Join Denise Belsham, PhD, and Deborah Kurrasch, PhD, on Wednesday, October 15 at 12:00 PM ET as they discuss the journey from discovery to disclosure of intellectual property to starting a viable biotech company: bit.ly/46LrgtF #EndoSky #endocrinology
endocrinesociety.bsky.social
“Planning for ENDO 2026 is well underway! Thanks to our community, the Annual Meeting Steering Committee had over 300 proposals to choose from for the program. Your input is what makes ENDO a success. Stay tuned for updates!” — Janel Johnson, Director, Event Education Design
endocrinesociety.bsky.social
Over the weekend, our Annual Meeting Steering Committee (AMSC) gathered to lay out the groundwork for ENDO 2026 in Chicago, Illinois on June 13–16! We would like to extend our gratitude to everyone on the AMSC for their hard work: bit.ly/4n9vcuB #endocrinology #ENDO2026
Reposted by Endocrine Society
endocrinesociety.bsky.social
The #FLARE2026 program offers early career researchers leadership training, mentorship, and practical career development. Roshaneh Ali, MD, was one of the 25 participants in FLARE last year. Listen to her story to hear how the program is already making an impact on her career: https://bit.ly/42mWKot
Roshaneh Ali | Future Leaders Advancing Research in Endocrinology (FLARE)
Roshaneh Ali was one of the 25 participants in Future Leaders Advancing Research in Endocrinology (FLARE) last year. Listen to her story to hear how the program is already making an impact on her career. Our FLARE program helps early career researcher...
bit.ly
endocrinesociety.bsky.social
Animal Model Explores Visual Cues and Overeating | A mouse study found watching others eat tasty foods could lead to overeating, even in the absence of hunger. Xu Xu, MD, describes the findings she and co-authors presented at ENDO: https://bit.ly/4nXGNx9 #ENDO2025 #endocrinology #EndoSky
YouTube
Share your videos with friends, family, and the world
bit.ly
endocrinesociety.bsky.social
Interrupted Anti-obesity Medication Access | People taking anti-obesity medications continue to lose weight even when they face availability and access issues obtaining the medications, according to research presented at ENDO. Kaelen L. Mederios, MS, describes the study: https://bit.ly/3VJnPP6
YouTube
Share your videos with friends, family, and the world
bit.ly
endocrinesociety.bsky.social
Research Compares Intermittent Energy Restriction to Other Weight Loss Approaches | Data presented at ENDO found that intermittent energy restriction, time-restricted eating, and continuous energy restriction can lead to weight loss. Haohao Zhang, PhD, discusses the findings: https://bit.ly/3Kn5oxf
YouTube
Share your videos with friends, family, and the world
bit.ly
endocrinesociety.bsky.social
Anti-obesity Medications and Muscle Loss | An ENDO study suggested taking the anti-obesity medication semaglutide can raise the risk of muscle loss. Researcher Melanie Haines, MD, discussed the findings and how eating a protein-rich diet can have a protective effect: https://bit.ly/4nXVJeS
YouTube
Share your videos with friends, family, and the world
bit.ly